Tealwood Asset Management Inc Neurocrine Biosciences Inc Transaction History

Tealwood Asset Management Inc

  • $242 Million
  • Q4 2024

A detailed history of Tealwood Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Tealwood Asset Management Inc holds 11,911 shares of NBIX stock, worth $1.37 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
11,911
Previous 11,793 1.0%
Holding current value
$1.37 Million
Previous $1.36 Million 19.65%
% of portfolio
0.67%
Previous 0.59%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025
BUY
$111.62 - $139.44 $13,171 - $16,453
118 Added 1.0%
11,911 $1.63 Million
Q3 2024

Oct 08, 2024
SELL
$114.58 - $153.15 $12,145 - $16,233
-106 Reduced 0.89%
11,793 $1.36 Million
Q2 2024

Jul 09, 2024
SELL
$130.86 - $143.19 $14,263 - $15,607
-109 Reduced 0.91%
11,899 $1.64 Million
Q1 2024

Apr 11, 2024
SELL
$130.4 - $143.74 $32,208 - $35,503
-247 Reduced 2.02%
12,008 $1.66 Million
Q4 2023

Jan 08, 2024
SELL
$106.07 - $132.76 $23,229 - $29,074
-219 Reduced 1.76%
12,255 $1.62 Million
Q3 2023

Nov 08, 2023
SELL
$94.02 - $117.1 $33,941 - $42,273
-361 Reduced 2.81%
12,474 $1.4 Million
Q2 2023

Jul 26, 2023
SELL
$89.53 - $104.87 $19,607 - $22,966
-219 Reduced 1.68%
12,835 $1.21 Million
Q1 2023

Apr 12, 2023
BUY
$94.11 - $123.02 $2,729 - $3,567
29 Added 0.22%
13,054 $1.32 Million
Q4 2022

Jan 17, 2023
SELL
$106.72 - $127.06 $122,301 - $145,610
-1,146 Reduced 8.09%
13,025 $1.56 Million
Q3 2022

Nov 16, 2022
SELL
$92.03 - $107.81 $2,116 - $2,479
-23 Reduced 0.16%
14,171 $1.51 Million
Q2 2022

Jul 20, 2022
SELL
$75.79 - $100.07 $30,467 - $40,228
-402 Reduced 2.75%
14,194 $1.38 Million
Q1 2022

May 02, 2022
BUY
$72.45 - $94.81 $680,957 - $891,119
9,399 Added 180.85%
14,596 $1.37 Million
Q4 2021

Mar 15, 2022
SELL
$79.65 - $106.22 $560,258 - $747,151
-7,034 Reduced 57.51%
5,197 $443,000
Q3 2021

Dec 02, 2021
SELL
$86.18 - $99.03 $48,950 - $56,249
-568 Reduced 4.44%
12,231 $1.17 Million
Q1 2021

Jun 21, 2021
BUY
$87.57 - $119.4 $56,570 - $77,132
646 Added 5.32%
12,799 $1.25 Million
Q4 2020

Mar 09, 2021
BUY
$86.91 - $108.33 $532,845 - $664,171
6,131 Added 101.81%
12,153 $1.17 Million
Q3 2020

Dec 14, 2020
BUY
$96.16 - $135.15 $579,075 - $813,873
6,022 New
6,022 $579,000

Others Institutions Holding NBIX

# of Institutions
650
Shares Held
96.2M
Call Options Held
380K
Put Options Held
382K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Tealwood Asset Management Inc Portfolio

Follow Tealwood Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email